MK-2206 dihydrochloride A highly selective pan-Akt inhibitor activated by the pleckstrin homology domain

MK-2206 dihydrochloride (CAS 1032350-13-2)

MK-2206 dihydrochloride | CAS 1032350-13-2 is rated 5.0 out of 5 by 1.
  • y_2018, m_10, d_21, h_21
  • bvseo_bulk, prod_bvrr, vn_bulk_2.0.8
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_364537, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 87ms
  • REVIEWS, PRODUCT
| See product citations (13)
Application: A highly selective pan-Akt inhibitor activated by the pleckstrin homology domain
CAS Number: 1032350-13-2
Molecular Weight: 480.39
Molecular Formula: C25H21N5O•2HCl
* Refer to Certificate of Analysis for lot specific data (including water content).
Submit a review for this product and receive 15 CruzCredits

Ordering Information

PRODUCT NAME CATALOG # UNIT PRICE QTY FAVORITES
MK-2206 dihydrochloride sc-364537 5 mg $165.00
MK-2206 dihydrochloride sc-364537A 10 mg $309.00

MK-2206 is a highly selective inhibitor of Akt1, Akt2, and Akt3 with IC50 values of 8 nM, 12 nM and 65 nM, respectively. MK-2206 is an allosteric inhibitor and is activated by the pleckstrin homology domain. MK-2206 inhibits auto-phosphorylation of both Akt T308 and S473. MK-2206 also prevents Akt-mediated phosphorylation of downstream signaling molecules, including TSC2, PRAS40 and ribosomal S6 proteins. MK-2206 also shows synergistic responses in combination with cytotoxic agents such as erlotinib (sc-202154) or lapatinib (sc-353658) in lung NCI-H460 or ovarian A2780 tumor cells.

Physical State :
Solid
Solubility :
Soluble in DMSO (14 mg/ml at 25 °C), water (1 mg/ml at 25 °C), and ethanol (<1 mg/ml at 25 °C).
Storage :
Store at -20° C
Melting Point :
>225° C (dec.)
Refractive Index :
n20D ~1.76 (Predicted)
IC50 :
Akt1: IC50 = 8 nM; Akt2: IC50 = 12 nM; Akt3: IC50 = 65 nM
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
46930998
MDL Number :
MFCD14584463
SMILES :
C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N.Cl.Cl

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

You May Also Like

MK-2206 dihydrochlorideProduct Citations

See how others have used MK-2206 dihydrochloride. Click on the entry to view the PubMed entry .

Citations 1 to 10 of 13 total

PMID: # 28759639  Schlegel, P. et al. 2017. PLoS ONE. 12: e0182110.

PMID: # 28012535  Youn, CK. et al. 2017. Int. J. Pediatr. Otorhinolaryngol. 92: 61-66.

PMID: # 27990618  Ok, SH. et al. 2017. Cardiovasc. Toxicol. 17: 344-354.

PMID: # 26133373  Avey, D. et al. 2015. PLoS pathogens. 11: e1004993.

PMID: # 25686839  McKee, CM. et al. 2015. Oncotarget. 6: 3784-96.

PMID: # 25483829  Wang, F. et al. 2015. Oncol. Rep. 33: 675-84.

PMID: # 26149501  Le, OT. et al. 2015. Biochimica et biophysica acta. 1853: 2432-43.

PMID: # 26324774  Kim, KS. et al. 2015. Journal of immunology (Baltimore, Md. : 1950). 195: 3345-54.

PMID: # 24508121  Shen, HJ. et al. 2014. Biochim. Biophys. Acta. 1840: 1838-49.

PMID: # 24759991  Bai, X. et al. 2014. PloS one. 9: e96117.

Citations 1 to 10 of 13 total

How did you get this result &quot;MK-2206 is a highly selective inhibitor of Akt1, Akt2, and Akt3 with IC50 values of 8 nM, 12 nM and 65 nM, respectively. &quot;? Here, &quot; IC50 values of 8 nM, 12 nM and 65 nM&quot;?

Asked by: Suikoshin
Thank you for your inquiry. These values are taken from published literature on the compound, not tested in house. Please contact Technical Service by phone, (800)-457-3801 option 2, email &lt;scbt@scbt.com&gt;, or by live chat directly on our website, www.scbt.com if you have any further questions.
Answered by: Technical Service
Date published: 2017-04-11

What is this soluble in?

Asked by: SCM4
MK-2206 dihydrochloride is soluble in DMSO (14 mg/ml), water (1 mg/ml), and ethanol (&lt;1 mg/ml) at 25&deg;C.
Answered by: Tech Service 11
Date published: 2017-02-24
  • y_2018, m_10, d_21, h_21CST
  • bvseo_bulk, prod_bvqa, vn_bulk_2.0.8
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_2
  • loc_en_US, sid_364537, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 92ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from Kong Kong, X. et al. (PubMed 26167511) found that MK-2206, a highly selective inhibitor of Akt1, Akt2 and Akt3, completely abolished anti-glucotoxicity effect of FLZ. -SCBT Publication Review
Date published: 2015-07-16
  • y_2018, m_10, d_21, h_21
  • bvseo_bulk, prod_bvrr, vn_bulk_2.0.8
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_364537, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 9ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2018 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.